Literature DB >> 15723195

Suppressors of cytokine signaling in health and disease.

Jane C Tan1, Ralph Rabkin.   

Abstract

Cytokines consist of a large family of secreted proteins, including pro-inflammatory agents, growth hormone and erythropoietin, that utilize the Janus kinase (JAK) signal transducer and activator of transcription (STAT) signal transduction pathway to mediate many of their key physiologic and pathologic actions. These actions include cytokine-mediated inflammation, immunoregulation, hematopoiesis and growth. The JAK-STAT pathway is regulated by several processes, among which negative feedback regulation by the suppressors of cytokine signaling (SOCS), members of a family of eight proteins, is particularly important. Each cytokine induces one or more specific SOCS proteins that in turn down-regulate the signal initiated by the cytokine. Through their impact on the cytokine-activated JAK-STAT pathway, the SOCS proteins are involved in many diseases that come to the attention of the pediatric nephrologist. For example, an increase in the expression of SOCS-2 and -3 may be a cause of growth hormone resistance and thus may contribute to the growth retardation that affects children with chronic renal failure. Because of their obvious biologic importance, the SOCS proteins have been the subject of intense research that includes the development of strategies to utilize these proteins to control cytokine-induced JAK/STAT signal transduction for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723195     DOI: 10.1007/s00467-004-1766-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  80 in total

1.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

2.  Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.

Authors:  T Shouda; T Yoshida; T Hanada; T Wakioka; M Oishi; K Miyoshi; S Komiya; K Kosai; Y Hanakawa; K Hashimoto; K Nagata; A Yoshimura
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 3.  Derangements of the somatotropic hormone axis in chronic renal failure.

Authors:  B Tönshoff; W F Blum; O Mehls
Journal:  Kidney Int Suppl       Date:  1997-03       Impact factor: 10.545

4.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Authors:  R Garcia; T L Bowman; G Niu; H Yu; S Minton; C A Muro-Cacho; C E Cox; R Falcone; R Fairclough; S Parsons; A Laudano; A Gazit; A Levitzki; A Kraker; R Jove
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

Review 5.  The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons.

Authors:  H Sakamoto; I Kinjyo; A Yoshimura
Journal:  Leuk Lymphoma       Date:  2000-06

6.  Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance.

Authors:  Charles E Egwuagu; Cheng-Rong Yu; Meifen Zhang; Rashid M Mahdi; Stephen J Kim; Igal Gery
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

7.  Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2.

Authors:  K C Leung; N Doyle; M Ballesteros; K Sjogren; C K W Watts; T H Low; G M Leong; R J M Ross; K K Y Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

8.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

Authors:  J A Johnston; M Kawamura; R A Kirken; Y Q Chen; T B Blake; K Shibuya; J R Ortaldo; D W McVicar; J J O'Shea
Journal:  Nature       Date:  1994-07-14       Impact factor: 49.962

9.  Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.

Authors:  Di Fei Sun; Zhilan Zheng; Padmaja Tummala; Jun Oh; Franz Schaefer; Ralph Rabkin
Journal:  J Am Soc Nephrol       Date:  2004-10       Impact factor: 10.121

10.  A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.

Authors:  A Yoshimura; T Ohkubo; T Kiguchi; N A Jenkins; D J Gilbert; N G Copeland; T Hara; A Miyajima
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  27 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Authors:  Mingming Zhao; Justyna A Janas; Masaru Niki; Pier Paolo Pandolfi; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 3.  Osteoporosis in chronic inflammatory disease: the role of malnutrition.

Authors:  Tiziana Montalcini; Stefano Romeo; Yvelise Ferro; Valeria Migliaccio; Carmine Gazzaruso; Arturo Pujia
Journal:  Endocrine       Date:  2012-10-09       Impact factor: 3.633

Review 4.  Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.

Authors:  Tim Ulinski; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2006-05-10       Impact factor: 3.714

5.  Endotoxin-induced growth hormone resistance in skeletal muscle.

Authors:  Yu Chen; Sumita Sood; Vidya M R Krishnamurthy; Peter Rotwein; Ralph Rabkin
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

6.  Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.

Authors:  Antonio DiGiandomenico; Lukasz S Wylezinski; Jacek Hawiger
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

7.  Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse.

Authors:  Chidozie J Amuzie; Junko Shinozuka; James J Pestka
Journal:  Toxicol Sci       Date:  2009-07-22       Impact factor: 4.849

8.  Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.

Authors:  Yaojun Liang; Yu Jin; Yuning Li
Journal:  Pediatr Nephrol       Date:  2009-04-07       Impact factor: 3.714

9.  Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.

Authors:  Matthew E Talbert; Carl D Langefeld; Julie Ziegler; Josyf C Mychaleckyj; Steven M Haffner; Jill M Norris; Donald W Bowden
Journal:  Hum Genet       Date:  2008-12-13       Impact factor: 4.132

10.  Mutations of HNF-1beta inhibit epithelial morphogenesis through dysregulation of SOCS-3.

Authors:  Zhendong Ma; Yimei Gong; Vishal Patel; Courtney M Karner; Evelyne Fischer; Thomas Hiesberger; Thomas J Carroll; Marco Pontoglio; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.